Baijiu plate strength, mouth cellar line exceeds 10%

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

SMEC Obtained IPO Approval from SSE Listing Committee

Shaoxing Semiconductor Manufacturing Corporation (SMEC) (Chinese: 中芯集成) obtained IPO approval at the listing committee meeting of the SSE Science and Technology Board on November 25. The underwriter of this IPO is Haitong Securities, which intends to raise CNY 12.5 billion (USD 1.75 billion).

EDA Solution Provider X-EPIC Bags Hundreds of Mns of CNY from Series B Funding Round

X-EPIC, an EDA solution provider, bagged hundreds of millions of CNY from Series B financing round, led by CLP Zhongjin(Xiamen)Smart Industry Equity Investment Fund Partnership(L.P.).

Q3 2022 Report for Meituan: Revenue Up 28.2% YoY to CNY 62.6 billion

Digital transformation of Chinese lifestyle services and retail industry is increasing at a rapid pace

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.